BC
Bridgefront Capital Portfolio holdings
AUM
$377M
This Quarter Return
+11.3%
1 Year Return
+12.67%
3 Year Return
+37.61%
5 Year Return
–
10 Year Return
–
AUM
$132M
AUM Growth
+$132M
(-7.1%)
Cap. Flow
-$15.7M
Cap. Flow
% of AUM
-11.85%
Top 10 Holdings %
Top 10 Hldgs %
9.93%
Holding
597
New
228
Increased
46
Reduced
73
Closed
250
Top Buys
| 1 |
Five Below
FIVE
|
$1.34M |
| 2 |
Starbucks
SBUX
|
$1.29M |
| 3 |
Equifax
EFX
|
$1.27M |
| 4 |
Ralph Lauren
RL
|
$1.27M |
| 5 |
Humana
HUM
|
$1.19M |
Top Sells
| 1 |
McDonald's
MCD
|
$1.77M |
| 2 |
American Express
AXP
|
$1.56M |
| 3 |
Apple
AAPL
|
$1.4M |
| 4 |
Hasbro
HAS
|
$1.37M |
| 5 |
Adobe
ADBE
|
$1.33M |
Sector Composition
| 1 | Consumer Discretionary | 20.04% |
| 2 | Technology | 17.37% |
| 3 | Industrials | 11.14% |
| 4 | Financials | 10.36% |
| 5 | Healthcare | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Westlake Corp
WLK
$11.1B
| $329K | 0.25% |
+2,348
| New | +$329K |
|
152
First Bancorp
FBP
$3.53B
| $328K | 0.25% |
19,930
+1,532
| +8% | +$25.2K |
|
153
Hilton Grand Vacations
HGV
$4.15B
| $326K | 0.25% |
+8,123
| New | +$326K |
|
154
Neurocrine Biosciences
NBIX
$14B
| $323K | 0.24% |
+2,453
| New | +$323K |
|
155
Tesla
TSLA
$1.07T
| $323K | 0.24% |
+1,298
| New | +$323K |
|
156
Avery Dennison
AVY
$13.3B
| $322K | 0.24% |
+1,595
| New | +$322K |
|
157
ASML
ASML
$285B
| $320K | 0.24% |
423
-238
| -36% | -$180K |
|
158
Evergy
EVRG
$16.3B
| $318K | 0.24% |
6,090
-2,828
| -32% | -$148K |
|
159
NCR Voyix
VYX
$1.8B
| $317K | 0.24% |
+18,767
| New | +$317K |
|
160
Pentair
PNR
$17.4B
| $314K | 0.24% |
4,317
-1,358
| -24% | -$98.7K |
|
161
General Motors
GM
$55.1B
| $313K | 0.24% |
+8,719
| New | +$313K |
|
162
Essential Utilities
WTRG
$11.1B
| $313K | 0.24% |
+8,381
| New | +$313K |
|
163
Golar LNG
GLNG
$4.42B
| $312K | 0.24% |
+13,570
| New | +$312K |
|
164
Buckle
BKE
$2.9B
| $312K | 0.24% |
+6,560
| New | +$312K |
|
165
Alcoa
AA
$7.9B
| $312K | 0.24% |
+9,168
| New | +$312K |
|
166
DexCom
DXCM
$29.4B
| $311K | 0.24% |
+2,510
| New | +$311K |
|
167
BorgWarner
BWA
$9.15B
| $311K | 0.23% |
+8,673
| New | +$311K |
|
168
Cummins
CMI
$54.2B
| $309K | 0.23% |
+1,291
| New | +$309K |
|
169
McCormick & Company Non-Voting
MKC
$18.7B
| $307K | 0.23% |
4,480
+945
| +27% | +$64.7K |
|
170
Wendy's
WEN
$1.97B
| $302K | 0.23% |
15,493
-12,421
| -44% | -$242K |
|
171
Cigna
CI
$80.7B
| $299K | 0.23% |
997
-2,382
| -70% | -$713K |
|
172
Equity Lifestyle Properties
ELS
$11.6B
| $298K | 0.23% |
+4,231
| New | +$298K |
|
173
Takeda Pharmaceutical
TAK
$47.9B
| $297K | 0.22% |
20,800
-3,135
| -13% | -$44.7K |
|
174
MetLife
MET
$53.1B
| $297K | 0.22% |
+4,484
| New | +$297K |
|
175
Commault Systems
CVLT
$7.87B
| $296K | 0.22% |
3,713
+86
| +2% | +$6.87K |
|